BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Novartis
Moodys
Colorcon
Healthtrust
Daiichi Sankyo
Federal Trade Commission
Fish and Richardson
Deloitte
Cantor Fitzgerald

Generated: January 18, 2018

DrugPatentWatch Database Preview

DICLOFENAC POTASSIUM Drug Profile

« Back to Dashboard

Which patents cover Diclofenac Potassium, and what generic alternatives are available?

Diclofenac Potassium is a drug marketed by Bionpharma Inc, Par Form, Apotex, Mylan, Sandoz, Sun Pharm Industries, Teva, and Watson Labs Teva. and is included in nine NDAs.

The generic ingredient in DICLOFENAC POTASSIUM is diclofenac potassium. There are forty-seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the diclofenac potassium profile page.

US Patents and Regulatory Information for DICLOFENAC POTASSIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bionpharma Inc DICLOFENAC POTASSIUM diclofenac potassium CAPSULE;ORAL 204648-001 Feb 23, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Industries DICLOFENAC POTASSIUM diclofenac potassium TABLET;ORAL 075470-001 Feb 21, 2002 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan DICLOFENAC POTASSIUM diclofenac potassium TABLET;ORAL 075463-001 Jul 26, 1999 AB RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva DICLOFENAC POTASSIUM diclofenac potassium TABLET;ORAL 075219-001 Aug 6, 1998 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Par Form DICLOFENAC POTASSIUM diclofenac potassium FOR SOLUTION;ORAL 202964-001 May 2, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex DICLOFENAC POTASSIUM diclofenac potassium TABLET;ORAL 076561-001 Mar 18, 2004 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz DICLOFENAC POTASSIUM diclofenac potassium TABLET;ORAL 075582-001 Feb 23, 2001 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz DICLOFENAC POTASSIUM diclofenac potassium TABLET;ORAL 075229-001 Nov 20, 1998 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs Teva DICLOFENAC POTASSIUM diclofenac potassium TABLET;ORAL 075152-001 Nov 27, 1998 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Cantor Fitzgerald
Julphar
McKinsey
Farmers Insurance
Harvard Business School
Healthtrust
Covington
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot